Immune composition and its association with hematologic recovery after chemotherapeutic injury in acute myeloid leukemia

Keane Jared Guillaume Kenswil, Paola Pisterzi, Jacqueline Feyen, Mariëtte ter Borg, Elwin Rombouts, Eric Braakman, Marc Hermanus Gerardus Petrus Raaijmakers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
21 Downloads (Pure)


Chemotherapy-induced bone marrow (BM) injury is a significant cause of morbidity and mortality in acute myeloid leukemia (AML). Time to hematologic recovery after standard (“7 + 3”) myeloablative chemotherapy can vary considerably among patients, but the factors that drive or predict BM recovery remain incompletely understood. Here, we assessed the composition of innate and adaptive immune subsets in the regenerating BM (day 17) after induction chemotherapy and related it to hematologic recovery in AML. T cells, and in particular the CD4 central memory (CD4CM) T-cell subset, were significantly enriched in the BM after chemotherapy, suggesting the relative chemoresistance of cells providing long-term memory for systemic pathogens. In contrast, B cells and other hematopoietic subsets were depleted. Higher frequencies of the CD4CM T-cell subset were associated with delayed hematopoietic recovery, whereas a high frequency of natural killer (NK) cells was related to faster recovery of neutrophil counts. The NK/CD4CM ratio in the BM after chemotherapy was significantly associated with the time to subsequent neutrophil recovery (Spearman's ρ = –0.723, p < 0.001, false discovery rate <0.01). The data provide novel insights into adaptive immune cell recovery after injury and identify the NK/CD4CM index as a putative predictor of hematopoietic recovery in AML.

Original languageEnglish
Pages (from-to)32-38.e2
JournalExperimental Hematology
Early online date17 Nov 2021
Publication statusPublished - Jan 2022

Bibliographical note

Publisher Copyright: © 2021 ISEH – Society for Hematology and Stem Cells


Dive into the research topics of 'Immune composition and its association with hematologic recovery after chemotherapeutic injury in acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this